We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $5K invested in Adial Pharmaceuticals Warrant in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

44% less capital invested

Capital invested by funds: $9K → $5K (-$4K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$2.99K
2
UBS Group
UBS Group
Switzerland
+$824

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$3K +$824 +1,242 +33%
WAM
2
Wolverine Asset Management
Illinois
$2K +$2.99K +4,504 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$8K -21,686 Closed

ADILW Hedge Fund Activity: Q1 2021 in Review

2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q1 2021, worth a combined $5K — down 44% from $9K a quarter earlier.

Fund positioning in ADILW was balanced in Q1 2021: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $2.99K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $8K sold.

  • 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $5K of Adial Pharmaceuticals Warrant stock for Q1 2021, down 44% quarter-over-quarter.
  • 1 fund opened new Adial Pharmaceuticals Warrant positions in Q1 2021 and 1 closed out, a net change of 0 holders.
  • The largest Adial Pharmaceuticals Warrant buyer in Q1 2021 was Wolverine Asset Management, an estimated $2.99K added.
  • The largest Adial Pharmaceuticals Warrant seller in Q1 2021 was Susquehanna International Group, an estimated $8K sold.

Based on aggregated 13F filings for Q1 2021.